Dodovislactone A exhibits significant antifungal activity, particularly against plant-pathogenic fungi such as Fusarium oxysporum and Botrytis cinerea. It is primarily investigated for use in agricultural protection, where it acts as a natural fungicide to prevent crop diseases. Its mode of action involves disrupting fungal cell membrane integrity, leading to inhibition of mycelial growth. Due to its natural origin and targeted efficacy, it is considered a promising candidate for development in eco-friendly pest management strategies. Additionally, preliminary studies suggest potential anti-inflammatory properties, particularly in cell models related to chronic diseases such as rheumatoid arthritis and type 2 diabetes. It shows potential in inhibiting proteins involved in the NF-κB signaling pathway, which plays a key role in regulating inflammation. Currently, it is not used in clinical or medical industry settings, as it is still in the preliminary research stage, prompting further research into pharmaceutical applications.